Android app Apple app link

AbbVie Inc. (ABBV) Analyst Forecast

NYSE Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$223.23
Day's range
$230.68

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
04/10/2026 Guggenheim Vamil Divan $249.00 $210.15   18.49%
02/24/2026 RBC Capital Trung Huynh $260.00 $228.44   13.82%
02/04/2026 Evercore ISI Gavin Clark-Gartner $228.00 $217.02   5.06%
01/28/2026 Goldman Sachs Asad Haider $223.00 $219.77   1.47%
01/15/2026 BMO Capital Evan David Seigerman $258.00 $217.74   18.49%
11/05/2025 Piper Sandler David Amsellem $289.00 $213.57   35.32%
11/03/2025 Raymond James Gary Nachman $256.00 $218.04   17.41%
10/17/2025 Raymond James Gary Nachman $250.00 $226.87   10.2%
09/15/2025 Cantor Fitzgerald Carter Gould $245.00 $218.34   12.21%
02/03/2025 Raymond James Gary Nachman $220.00 $190.14   15.7%
02/03/2025 BMO Capital Evan Seigerman $215.00 $190.14   13.07%
11/12/2024 BMO Capital Evan David Seigerman $208.00 $201.61   3.17%
10/31/2024 BMO Capital Evan David Seigerman $228.00 $201.50   13.15%
10/31/2024 Bank of America Securities Charlie Yang $210.00 $201.50   4.22%
10/31/2024 Citigroup Geoff Meacham $226.00 $201.50   12.16%
10/18/2024 Bank of America Securities Geoff Meacham $195.00 $188.57   3.41%
10/17/2024 Bernstein Courtney Breen $203.00 $190.46   6.58%
08/23/2024 Raymond James Christopher Raymond $209.00 $197.35   5.9%
07/19/2024 BMO Capital Evan Seigerman $214.00 $172.01   24.41%
06/18/2024 Raymond James Christopher Raymond $190.00 $171.36   10.88%
06/05/2024 HSBC Rajesh Kumar $185.00 $162.14   14.1%
05/24/2024 Deutsche Bank James Shin $175.00 $156.96   11.49%
05/17/2024 Cantor Fitzgerald Louise Chen $200.00 $164.35   21.69%
04/29/2024 BMO Capital Evan Seigerman $180.00 $158.58   13.5%
03/26/2024 Barclays Carter Gould $195.00 $179.79   8.46%
01/29/2024 William Blair Tim Lugo $190.00 $163.91   15.92%
11/09/2023 Raymond James Christopher Raymond $170.00 $142.03   19.69%
09/29/2023 Raymond James Gary Nachman $177.00 $149.12   18.7%
05/09/2023 Guggenheim Vamil Divan $171.00 $147.01   16.32%
04/25/2022 BMO Capital Gary Nachman $174.00 $157.72   10.33%
02/02/2022 Barclays Carter Gould $150.00 $140.73   6.59%
02/02/2022 J.P. Morgan Chris Schott $180.00 $140.73   27.9%
02/01/2022 Piper Sandler Christopher Raymond $160.00 $138.62   15.42%
01/31/2022 Evercore ISI Joshua Schimmer $133.00 $137.00   -2.92%
01/17/2022 Cowen & Co. Steve Scala $150.00 $136.78   9.67%
01/02/2022 Bernstein Aaron Gal $155.00 $134.03   15.65%
12/07/2021 Wells Fargo Mohit Bansal $165.00 $120.62   36.79%
11/22/2021 Societe Generale Justin Smith $172.00 $117.66   46.18%
08/04/2021 Argus Research David Toung $140.00 $112.57   24.37%
07/31/2021 RBC Capital Daniel Busby $135.00 $112.90   19.57%
05/02/2021 Wolfe Research Tim Anderson $127.00 $110.91   14.51%

Abbvie Inc FAQ's

Abbvie Inc has been rated by research analysts at Morgan Stanley, Piper Sandler, Canaccord Genuity, Guggenheim, Cantor Fitzgerald, RBC Capital in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.